12:00 AM
Jan 17, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Status

PVAC: Started Phase II trials

Corixa Corp. (CRXA), Seattle, Wash.
Product: PVAC
Business: Autoimmune/Inflammation
Therapeutic category: Immune modulation
Target: Immune system...

Read the full 58 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >